With the identification of HMGA2 as a potential target for the treatment of obesity and cancer, the next step is to search for chemical compounds that prevent HMGA2 binding to its target DNA sequences. The gene discussed is HMGA2; the disease is obesity due to melanocortin 4 receptor deficiency.